How Can We Help?
You are here:
< Back

Lidanserin (INN; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist.[1] It was developed as an antihypertensive agent but was never marketed.[1]

See also

References

  1. ^ a b Allen RC (1989). Annual Reports in Medicinal Chemistry. Academic Press. p. 56. ISBN 978-0-12-040524-4. Retrieved 6 May 2012.
Categories
Table of Contents